Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, January 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

policy: 1 policy source

patent: 3 patents

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 38 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Nivolumab for treating relapsed or refractory classical Hodgkin lymphoma: Committee papers

Cited by National Institute for Health and Care Excellence on 06 Mar 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.